Lorenzo Falchi, M.D.
Medical Oncology Physician · New York, NY
Lorenzo Falchi, M.D. is a medical oncology physician with a practice address in New York, New York, and NPI 1417392937, issued on May 10, 2013. Check the license (New York 286744, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.
- Name
- Lorenzo Falchi
- Credential
- M.D.
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- 286744 NY
Self-reported in NPPES; status is on the state search - Practice location
- 1275 York Ave, New York, NY 10065
- Phone
- (212) 639-2000
- Enumerated
- May 10, 2013
- Record last updated
- Aug 2, 2019 (not updated in 7 years: call before relying on the address or phone)
- Medicare enrollment
- Enrolled (PECOS I20190925003387); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 1275 York Ave
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Nivedita Aanur, M.D.Internal Medicine Physician1982833471
- Amy Aaronson, AC-PNP, RNCritical Care Pediatric Nurse Practitioner1407323504
- Michelle Abboud, N.P.Acute Care Nurse Practitioner1730596008
- Gina Abdulahad, PA-CPhysician Assistant1174027064
- Wassim Abida, MD, PHDHematology & Oncology Physician1518101096
- Ghassan Abou-Alfa, MDMedical Oncology Physician1134190168
Verify Lorenzo Falchi in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
Search for license 286744Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
24% fewer Medicare Part D claims than the average medical oncology physician in 2024
534 Medicare Part D claims for 93 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 11% of claims.
Most prescribed
- Acyclovir164 claims
- Sulfamethoxazole-Trimethoprim58 claims
- Pantoprazole Sodium46 claims
- Prednisone46 claims
- Calquence28 claims
- Ondansetron Hcl20 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 93.5 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $27,608.42
27 payments; by number, the most common kind was food and beverage; the largest payer was Adc Therapeutics America, Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Memorial Hematology Lymphoma GroupNew York, NY
- Msk NassauUniondale, NY
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Medical Oncology Physician providers in New York
There are 548 medical oncology physician records in New York.
Other medical oncology physician records in New York
- Anuja AbhyankarBuffalo, NY1679181424
- Ghassan Abou-Alfa, MDNew York, NY1134190168
- Nour AbuhadraNew York, NY1598146227
- Melissa AccordinoNew York, NY1740422039
- David Aggen, M.D., PH.D.New York, NY1194168955
- Carol Aghajanian, MDNew York, NY1275570533
- Omobolaji Akala, MD/PHDNew York, NY1366735722
- Duaa Al Rawi, MD PHDNew York, NY1356838353
- Louis Aledort, MDNew York, NY1861424061
- Reem AlsuwailemNew York, NY1689412801
Common questions
What is Lorenzo Falchi, M.D.'s NPI number?
Lorenzo Falchi, M.D.'s National Provider Identifier (NPI) is 1417392937, issued on May 10, 2013. An NPI identifies a provider in billing; it is not a license.
Where is Lorenzo Falchi, M.D. located?
The NPPES record lists a practice address at 1275 York Ave, New York, NY, 10065. Phone: (212) 639-2000. Providers update this record themselves, so call before visiting.
How can I verify Lorenzo Falchi, M.D.'s license?
NPPES lists New York license number 286744, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Lorenzo Falchi, M.D. prescribe under Medicare Part D?
In 2024, Lorenzo Falchi, M.D. had 534 Medicare Part D claims for 93 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
What is Lorenzo Falchi, M.D.'s MIPS final score?
The 2023 MIPS final score is 93.5 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.